Alterations in proteolytic activity at low pH and its association with invasion: A theoretical model

Clinical and Experimental Metastasis

Volumn 17, Issue 5, 1999, Pages 397-407

  Webb, Steven D ^a   Sherratt, Jonathan A ^a   Fish, Reginald G ^b  

^a HERIOT WATT UNIVERSITY   (United Kingdom)

^b VELINDRE CANCER CENTRE   (United Kingdom)

Author keywords

Cysteine proteinases; Invasion; Metalloproteinases; Modelling

Indexed keywords

CATHEPSIN B; CYSTEINE PROTEINASE; METALLOPROTEINASE;

ARTICLE; CANCER INVASION; CELL PH; ENZYME ACTIVATION; ENZYME ACTIVITY; EXOCYTOSIS; EXTRACELLULAR MATRIX; GLYCOLYSIS; MATHEMATICAL MODEL; PROTEIN DEGRADATION; SOLID TUMOR; THEORY;

CELL MOVEMENT; HUMANS; HYDROGEN-ION CONCENTRATION; MODELS, BIOLOGICAL; MODELS, THEORETICAL; NEOPLASM INVASIVENESS; NEOPLASMS;

EID: 0033380522     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006667303583     Document Type: Article

References (60)

1. 1. Warburg O. The metabolism of tumours. London: Constable 1930.
2. 2. Tannock IF, Rotin D. Acid pH in tumours and its potential for therapeutic exploitation. Cancer Res 1989; 49: 4373-84.
3. 3. Kallinowski F, Vaupel P, Runkel S. Glucose uptake, lactate release, ketone body turnover, metabolic micromilieu and pH distributions in human breast cancer xenografts in nude rats. Cancer Res 1988; 48: 7264-72.
4. 4. Hoffman FA. Metabolic changes in malignancy. In Liotta LA (ed): Cancer Growth and Progression. Boston: Kluwer Academic Publishers 1989; 18-27.
5. 5. Hawkins RA, Hoh C, Glaspy J et al. PET-FDG imaging in cancer. Appl Radiol 1992; 5: 51-7.
6. 6. Stubbs M, Rodrigues L, Howe FA et al. Metabolic consequences of a reversed pH gradient in rat tumours. Cancer Res 1994; 54: 4011-16.
7. 7. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review. Cancer Res 1989; 49: 6449-65.
8. 8. Boyer MJ, Tannock IF. Regulation of intracellular pH in tumor cell lines: Influence of microenvironmental conditions. Cancer Res 1992; 52: 4441-47.
9. + exchanger for tumor growth. Cancer Res 1989; 49: 205-11.
10. 10. Gerweck LE, Seetharaman K. Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. Cancer Res 1996; 56: 1194-98.
11. 11. Busa WB, 1986, Mechanisms and consequences of pH-mediated cell regulation. Ann Rev Physiol 1986; 48: 389-402.
12. 12. Gillies RJ, Martinez-Zaguilan R, Peterson EP, Perona R. Role of intracellular pH in mammalian cell proliferation. Cell Physiol Biochem 1992; 2: 159-79.
13. 13. Martinez-Zaguilan R, Seftor EA, Seftor REB et al. Acidic pH enhances the invasive behaviour of human melanoma cells. Clin Exp Metastasis 1996; 14: 176-86.
14. 14. Liotta LA, Stetler-Stevenson WG. Principles of molecular cell biology of cancer: Cancer metastasis. Cancer: Principles & Practice of Oncology. Philadelphia: Lippincott Co. 1993; 134-49.
15. 15. Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997; 89: 1260-70.
16. 16. Kato Y, Nakayama Y, Umeda M, Miyazaki K. Induction of 103-kDa gelatinase/type IV collagenase by acidic culture conditions in mouse metastatic melanoma cell lines. J Biol Chem 1992; 267: 11424-30.
17. 17. Powell WC, Matrisian LM. Complex roles of matrix metalloproteinases in tumour progression. Curr Topics Microbiol Immunol 1996; 213: 1-21.
18. 18. Woessner JF. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991; 5: 1245-54.
19. 19. Duffy MJ. The role of proteolytic enzymes in cancer invasion and metstasis. Clin Exp Metstasis 1992; 10: 145-55.
20. 20. Mignatti P, Rifkin DB. Membrane and matrix localization of proteinases in tumour invasion. Physiol Rev 1993; 73: 161-95.
21. 21. Stetler-Stevenson WG, Liotta LA, Kleiner Jr DE. Extracellular matrix: Role of matrix metalloproteinases in tumour invasion and metstasis. FASEB J 1993; 7: 1434-41.
22. 22. Sato H, Takino T, Okada Y et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994; 370: 61-5.
23. 23. Birkedal-Hansen H. Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 1995; 73: 728-35.
24. 24. Ishihara A, Nabeshima K, Koono M. Partial purification and characterization of serum protease form tumor-bearing rats which cleaves type IV collagen. Invasion Metastasis 1986; 6: 225-45.
25. 25. Rozhin J, Sameni M, Ziegler G, Sloane BF. Pericellular pH affects distribution and secretion of cathepsin B in malignant cells. Cancer Res 1994; 54: 6517-25.
26. 26. Ward JP, King JR. Mathematical modelling of avascular tumour growth. IMA J Math Appl Med Biol 1997; 14: 39-69.
27. 27. Adam JA. A mathematical model of tumour growth. 2. Effects of geometry and spatial non-uniformity on stability. Math. Biosci 1987; 86: 183-211.
28. 28. Burton AC. Rate of growth of solid tumours as a problem of diffusion. Growth 1966; 30: 159-76.
29. 29. Chaplain MAJ, Sleeman BD. A mathematical model for the production and secretion of tumour angiogenesis factor in tumours. IMA J Math Appl Med Biol 1990; 7: 93-108.
30. 30. Byrne HM, Chaplain MAJ. Mathematical models for tumour angiogenesis - numerical simulations and non-linear wave solutions. Bull Math Biol 1995; 57: 461-86.
31. 31. Sherratt JA, Nowak MA. Oncogenes, anti-oncogenes and the immune response to cancer: A mathematical model. Proc R Soc Lond 1992; B248: 261-71.
32. 32. Grossman Z, Berke G. Tumour escape from immune elimination. J Theor Biol 1980; 51: 317-40.
33. 33. Owen MR, Sherratt JA. Pattern formation and spatiotemporal irregularity in a model for macrophage-tumour interaction. J Theor Biol 1997; 189: 63-80.
34. 34. Adam JA, Bellomo N. A Survey of Models for Tumour-Immune System Dynamics. Boston: Birkhauser 1997.
35. 35. Perumpanani AJ, Sherratt JA, Norbury J, Byrne HM, 1996, Biological inferences from a mathematical model for malignant invasion. Invasion Metastasis 1996; 16: 209-21.
36. 36. Gatenby RA, Gawlinski ET. A reaction-diffusion model of cancer invasion. Cancer Res 1996; 56: 5745-53.
37. 37. Gatenby RA. Altered glucose metabolism and the invasive tumour phenotype: Insights provided through mathematical models (Review). Int J Oncol 1996; 8: 597-601.
38. 38. Webb SD, Sherratt JA, Fish RG. Mathematical modelling of tumour acidity: regulation of intracellular pH. J Theor Biol 1999; 196: 237-50.
39. 39. Hochachka PW, Mommsen TP. Protons and Anaerobiosis. Science 1983; 219: 1391-7.
40. 40. Busa WB, Nucatelli R. Metabolic regulation via intracellular pH. Am J Physiol 1984; 246: R409-38.
41. 41. Roos A, Boron WF. Intracellular pH. Physiol Rev 1981; 61: 296-434.
42. 2 gradients in solid tumours in vivo: High-resolution reveal a lack of correlation. Nature Med 1997; 3: 177-81.
43. 43. Casciari JJ, Otirchos SV, Sutherland RM. Variations in tumour growth rates and metabolism with oxygen concentration, glucose concentration, and extracellular pH. J Cell Physiol 1992; 151: 386-94.
44. 44. Vassalli J, Pepper S. Membrane proteases in focus. Nature 1994; 370: 14-5.
45. 45. Davis GE, Martin BM. A latent MR 94,000 gelatin-degrading metalloproteinase induced during differentiation of HL-60 promyelocytic leukemia cells - a member of the collagenase family of enzymes. Cancer Res 1990; 50: 1113-20.
46. 46. Kramer MD, Robinson P, Vlodavsky I et al. Characterization of an extracellular matrix-degrading protease derived from a highly metastatic tumour cell line. Eur J Cancer Clin Oncol 1985; 21: 307-16.
47. 47. Turner GA. Increased release of tumour cells by collagenase at acid pH: a possible mechanism for metastasis. Experimentia 1979; 35: 1657-8.
48. 48. Jang A, Hill RP. An examination of the effect of hypoxia acidosis, and glucose starvation on the expression of metastasis-associated genes in murine tumor cells. Clin Exp Metastasis 1997; 15: 469-83.
49. 49. Briozzo P, Morisset M, Capony F et al. In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells. Cancer Res 1988; 48: 3688-92.
50. 50. Van der Stappen JWJ, Williams AC, Maciewicz RA, Paraskeva C. Activation of cathepsin B, secreted by a colorectal cancer cell line requires low pH and is mediated by cathepsin D. Int J Cancer 1996; 67: 547-54.
51. 51. Chambers AF, Colella R, Denhardt DT, Wilson SM. Increased expression of cathepsins L and B and decreased activity of their inhibitors in metastatic, ras-transformed NIH 3T3 cells. Mol Carcin 1992; 5: 238-45.
52. 52. Qian F, Bajkowski AS, Steiner DF et al. Expression of five cathepsins in murine melanomas of varying metastatic potential and normal tissues. Cancer Res 1989; 49: 4870-5.
53. 53. Sartorelli AC. Therpeutic attack of hypoxic cells of solid tumors: Presidential address. Cancer Res 1988; 48: 775-8.
54. 54. Frelin C, Vigne P, Ladoux A, Lazdunski M. The regulation of the intracellular pH in cells from vertebrates. Eur J Biochem 1988; 174: 3-14.
55. 55. Strazzabosco M, Boyer MJ. Regulation of intracellular pH in the hepatocyte. J Hepatol 1996; 24: 631-4.
56. +-ATPases are functionally expressed in plasma membranes of human tumor-cells. Am J Physiol 1993; 265: C1015-29.
57. +-ATPase type in the ruffled borders of osteoclasts. J Cell Biol 1990; 111: 1305-11.
58. +-ATPase. Biochem 1992; 281: 245-50.
59. + exchange and growth factor induced cytosolic pH changes. Role in cellular proliferation. Biochim Biophys Acta 1989; 988: 73-97.
60. 60. Madshus IH. Regulation of intracellular pH in eukaryotic cells. Biochem J 1988; 250: 1-8.